Stocks › ARWR
Arrowhead Pharmaceuticals ARWR
US equityMarket cap rank #1888
$41.37 −$2.28 (-5.22%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $41.40 +0.07%
Open$43.15
Prev close$43.65
Day range$41.17 – $44.80
Volume3.91M
Market cap$5.85B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts11
Average target$106.63+157.7% vs. price
- Buy 91%
- Hold 9%
Low $74.00Now $41.37Avg $106.63High $126.00
Recent rating changes
The last 20 actions on file set price targets from $74.00 to $126.00, averaging $112.06.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 13 Nov 2026 | Piper Sandler | BUY | $126.00 |
| 13 Nov 2026 | BofA Securities | BUY | – |
| 13 Nov 2026 | Morgan Stanley | BUY | $106.00 |
| 13 Nov 2026 | Stifel | BUY | $96.00 |
| 13 Nov 2026 | RBC Capital | BUY | $100.00 |
| 11 Nov 2026 | H.C. Wainwright | BUY | $120.00 |
| 10 Nov 2026 | Piper Sandler | BUY | $126.00 |
| 10 Nov 2026 | B. Riley Securities | BUY | $123.00 |
| 5 Nov 2026 | H.C. Wainwright | BUY | $120.00 |
| 15 Oct 2026 | Piper Sandler | BUY | $126.00 |
| 15 Oct 2026 | H.C. Wainwright | BUY | $120.00 |
| 15 Oct 2026 | J.P. Morgan | BUY | – |
| 14 Oct 2026 | Citi | BUY | $108.00 |
| 14 Oct 2026 | H.C. Wainwright | BUY | $120.00 |
| 12 Oct 2026 | BofA Securities | BUY | $100.00 |
| 24 Sep 2026 | Goldman Sachs | HOLD | $74.00 |
| 21 Sep 2026 | H.C. Wainwright | BUY | $120.00 |
| 16 Sep 2026 | Citi | BUY | – |
| 15 Sep 2026 | J.P. Morgan | BUY | – |
| 9 Sep 2026 | Citi | BUY | $108.00 |
No comments yet — be the first to weigh in on ARWR.
Sign in to join the discussion.